The 17th Annual Traumatic Brain Injury
Conference
Advancing the Science, Understanding & Treatment of Traumatic Brain Injury
Join our LinkedIn TBI R&D Network Group & TBI News Twitter Feed
Welcome to Our 2027 Event!
Arrowhead Sci-Tech Conferences & Events is pleased to announce the 17th Annual Traumatic Brain Injury Conference, taking place May 17–18, 2027, in Washington, DC.
The Annual Traumatic Brain Injury Conference brings together leading TBI researchers, clinicians, physicians, neurosurgeons, scientists, and drug and diagnostic developers from academia, industry, the military, and government to explore the latest advances in traumatic brain injury research, diagnosis, treatment, and long-term care.
Now in its 17th year, the conference provides a collaborative forum for presenting new research and exchanging ideas across the TBI field. Attendees will hear about emerging science and clinical developments in areas such as TBI therapeutics, biomarkers and diagnostics, concussion, neurodegeneration, rehabilitation and outcomes research, preclinical research, and clinical studies.
By bringing together experts and stakeholders from across the global brain injury community, the conference offers a unique opportunity to share original research, build collaborations, and examine the progress being made toward better ways to diagnose, treat, and improve outcomes for people affected by traumatic brain injury..
About the Event
This year’s conference will bring together leading researchers, clinicians, and industry experts to explore the latest advances in traumatic brain injury (TBI) science, diagnosis, and treatment. Sessions will highlight cutting-edge research on the biological mechanisms of injury and recovery, the development of new biomarkers and imaging tools, and innovative therapeutic strategies.
In addition to scientific discovery, the program will emphasize long-term outcomes, clinical translation, and the importance of equitable access to care across diverse populations, including children, athletes, veterans, and survivors of intimate partner violence. By integrating perspectives from preclinical research, clinical practice, and public health, the meeting will provide a forward-looking view of how the field is evolving toward improved diagnosis, management, and recovery for individuals affected by TBI.
Why Attend?

Exhibitors & Service Providers

Panel Sessions

Scientific Poster Session

Networking Opportunities
Conference Topics & Themes
- Advances & Opportunities for TBI Biomarkers
- TBI Therapeutic Prelinical/Clinical Research
- Neuroimaging Research and Practice
- Outcomes Research and Links to Neurodegenerative Disorders
- Preclinical Models of TBI
- Large-scale Observational Studies of TBI
- Concussion in Sports
- Clinical Management of TBI
- Emerging Tools for Diagnosis/Assessment of TBI
- Pediatric TBI
2026 Featured Speakers

University of Pennsylvania

Icahn School of Medicine at Mount Sinai



Past Exhibitors & Sponsors































Past Companies & Organizations in Attendance
Who Should Attend
Neurobiologists
Presidents
Biomedical Engineers
Neurocritical Care Physicians
Principal Investigators
Business Development Executives
Neurological Surgeons
Principal Scientists
Chief Executive Officers
Neurologists
Program Managers
Chief Operating Officers
Neuropsychologists
Psychiatrists
Chief Scientific Officers
Neuroscientists
Reg. Affairs Managers & Directors
Clinical Pharmacology Fellows
Neurointensivists
Research Associates
Research Directors
Consultants
Medical Directors
Research Fellows
Critical Care Physicians
Medical Officers
Research Scientists
Emergency Medicine Physicians
Occupational Therapists
Sales Managers and Directors
Scientific Project Managers
Marketing Managers and Directors
Physical Med. & Rehab. Physicians
Scientists
Medical Science Liaisons
Physicians
Professors
Chief Medical Officers
Clinical Researchers
Group Leaders



